Shaha A R, Loree T R, Shah J P
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, N.Y., USA.
Surgery. 1995 Dec;118(6):1131-6; discussion 1136-8. doi: 10.1016/s0039-6060(05)80124-2.
The understanding of prognostic factors has facilitated stratification of risk groups in differentiated carcinoma of the thyroid. The prognostic factors have clearly identified the risk groups as low, intermediate, and high risk. Risk group categorization has facilitated a selective surgical approach for thyroid carcinoma.
A retrospective review of 228 patients with follicular carcinoma of the thyroid was undertaken. Various prognostic factors and risk groups were analyzed. Univariate and multivariate analyses were performed, and the survival curves were plotted by the Kaplan-Meier method. Fifty-nine (26%) patients presented with Hürthle cell histology. The risk groups revealed 62 patients in the low, 84 in the intermediate, and 82 in the high risk groups.
The 10-year survival for low, intermediate, and high risk groups was 98%, 88%, and 56%, respectively, and the 20-year survival for the same groups was 97%, 87%, and 49%, respectively. Adverse prognostic factors included age older than 45 years (p < 0.001), Hürthle cell variety (p = 0.05), extrathyroidal extension, tumor size exceeding 4 cm, and the presence or absence of distant metastasis (p < 0.001). Gender, focality, and presence of lymph node metastasis had no significant impact on prognosis.
Patients in the low risk group have excellent survival, whereas the high risk group behaves poorly. Appropriate selection of treatment for the primary disease and adjuvant therapy should be considered on the basis of the prognostic factors and risk group analysis.
对预后因素的理解有助于对分化型甲状腺癌的风险组进行分层。预后因素已明确将风险组分为低、中、高风险。风险组分类有助于对甲状腺癌采取选择性手术方法。
对228例甲状腺滤泡癌患者进行回顾性研究。分析了各种预后因素和风险组。进行单因素和多因素分析,并采用Kaplan-Meier法绘制生存曲线。59例(26%)患者为许特莱细胞组织学类型。风险组显示低风险组62例,中风险组84例,高风险组82例。
低、中、高风险组的10年生存率分别为98%、88%和56%,相同组别的20年生存率分别为97%、87%和49%。不良预后因素包括年龄大于45岁(p<0.001)、许特莱细胞类型(p = 0.05)、甲状腺外侵犯、肿瘤大小超过4 cm以及有无远处转移(p<0.001)。性别、病灶范围和有无淋巴结转移对预后无显著影响。
低风险组患者生存率极佳,而高风险组患者预后较差。应根据预后因素和风险组分析考虑对原发性疾病进行适当的治疗选择和辅助治疗。